ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for tools Level up your trading with our powerful tools and real-time insights all in one place.

OVID Ovid Therapeutics Inc

3.375
0.035 (1.05%)
Last Updated: 08:59:32
Delayed by 15 minutes
Share Name Share Symbol Market Stock Type
Ovid Therapeutics Inc OVID NASDAQ Common Stock
  Price Change Price Change % Share Price Last Trade
0.035 1.05% 3.375 08:59:32
Open Price Low Price High Price Close Price Previous Close
3.39 3.335 3.45 3.34
more quote information »

Recent News

Date Time Source Heading
4/04/202407:00GLOBEOvid Therapeutics to Present at the 23rd Annual Needham..
3/08/202407:24EDGAR2Form 10-K - Annual report [Section 13 and 15(d), not S-K..
3/08/202407:20EDGAR2Form 8-K - Current report
3/08/202407:00GLOBEOvid Therapeutics Reports Business Updates, Fourth Quarter..
2/28/202407:00GLOBEOvid Therapeutics to Present at the TD Cowen 44th Annual..
2/26/202417:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2/26/202417:01EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2/26/202417:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2/26/202416:56EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2/26/202416:53EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2/14/202410:10EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
2/12/202405:06EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
2/06/202407:00GLOBEOvid Therapeutics to Present at the Oppenheimer 34th Annual..
12/06/202316:08EDGAR2Form 8-K - Current report
12/01/202306:30GLOBEOvid Therapeutics to Present Five Abstracts Supporting its..
11/15/202323:15EDGAR2Form EFFECT - Notice of Effectiveness
11/15/202315:11EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
11/03/202315:08EDGAR2Form S-3 - Registration statement under Securities Act of..
11/03/202307:13EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
11/03/202307:10EDGAR2Form 8-K - Current report
11/03/202307:00GLOBEOvid Therapeutics Reports Third Quarter 2023 Financial..
10/18/202307:04EDGAR2Form 8-K - Current report
10/18/202307:00GLOBEOvid Therapeutics and Ligand Pharmaceuticals Enter into a..
10/10/202307:00GLOBEOvid Therapeutics to Present at the Jefferies Biotech..
10/02/202311:15EDGAR2Form 8-K - Current report
9/26/202306:30GLOBEOvid Therapeutics to Host Investor Event - R&D Day on..
9/20/202306:30GLOBEOvid Therapeutics to Present at the 2023 Cantor Fitzgerald..
8/30/202307:00GLOBEOvid Therapeutics to Participate in Upcoming September..
8/04/202308:23EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
8/04/202308:10EDGAR2Form 8-K - Current report
8/04/202307:00GLOBEOvid Therapeutics Reports Second Quarter 2023 Financial..
8/01/202307:00GLOBEOvid Therapeutics to Present at the BTIG Virtual..
7/31/202316:21EDGAR2Form SC 13G - Statement of acquisition of beneficial..
6/28/202307:00GLOBEOvid Therapeutics Expands Its Scientific Leadership Team &..
6/26/202307:00GLOBEOvid Therapeutics Added to Russell 3000® Index
5/05/202306:30GLOBEOvid Therapeutics Reports First Quarter 2023 Financial..
5/01/202305:00GLOBEOvid Therapeutics Announces Collaboration with Graviton..

Your Recent History

Delayed Upgrade Clock